Hydroxychloroquine shortages during the COVID-19 pandemic

Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20.
No abstract available

Keywords: antirheumatic agents; autoimmune diseases; epidemiology; hydroxychloroquine; lupus erythematosus, systemic.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic*
  • Pandemics
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine